Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 3.302.512.152.313.24

What is the latest Working Capital/Sales ratio of VENUS REMEDIES ?

The latest Working Capital/Sales ratio of VENUS REMEDIES is 3.30 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar20263.30
Mar20252.51
Mar20242.15
Mar20232.31
Mar20223.24

How is Working Capital/Sales of VENUS REMEDIES Trending?

Years Working Capital/Sales % Change
Mar2026 3.3
31.47
Mar2025 2.51
16.74
Mar2024 2.15
-6.93
Mar2023 2.31
-28.70
Mar2022 3.24 -

Other Financial Ratios of VENUS REMEDIES


Compare Working Capital/Sales ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹2,099.2 Cr -6.3% -12.9% 210.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,312.0 Cr 3.1% 7.2% 18.3% Stock Analytics
DIVIS LABORATORIES ₹213,879.0 Cr 8.2% 19.8% 17.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹194,094.0 Cr -1.8% 4.9% 37.2% Stock Analytics
CIPLA ₹118,992.0 Cr 3.9% 0.6% 0% Stock Analytics
DR REDDYS LABORATORIES ₹95,787.4 Cr -0.7% -14.6% -8.4% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-6.3%

-12.9%

210.1%

SENSEX

2.7%

1.5%

-5.6%


You may also like the below Video Courses